First National Trust’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

First National Trust’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-6	Closed	-$8K	–	313
2015 Q4	$8K	Hold	6	–	–	﹤0.01%	293
2015 Q3	$9K	Hold	6	–	–	﹤0.01%	293
2015 Q2	$14K	Hold	6	–	–	﹤0.01%	292
2015 Q1	$19K	Hold	6	–	–	﹤0.01%	266
2014 Q4	$21K	Hold	6	–	–	﹤0.01%	239
2014 Q3	$22K	Hold	6	–	–	﹤0.01%	245
2014 Q2	$24K	Hold	6	–	–	﹤0.01%	244
2014 Q1	$26K	Hold	6	–	–	﹤0.01%	239
2013 Q4	$24K	Hold	6	–	–	﹤0.01%	246
2013 Q3	$25K	Buy	+6	New	+$45K	﹤0.01%	233

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SAIG

Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

First National Trust's FRTX Position: Q1 2016 in Review

First National Trust sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2016, closing a stake of 6 shares — an estimated $8K sold.

First National Trust first reported a position in FRTX in Q3 2013 and held it in 10 quarters. The position peaked at $26K in Q1 2014. 43 funds tracked by Wall St. Rank hold FRTX as of Q1 2016.

First National Trust reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
First National Trust sold 6 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $8K.
First National Trust first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2013 and held it in 10 quarters.
First National Trust's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $26K in Q1 2014.
43 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2016.

Based on First National Trust's 13F filing for Q1 2016, filed 9 May 2016.